HealthStream (HSTM) Earns Daily Media Impact Score of 0.02

Media stories about HealthStream (NASDAQ:HSTM) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. HealthStream earned a media sentiment score of 0.02 on Accern’s scale. Accern also assigned press coverage about the technology company an impact score of 83 out of 100, indicating that recent media coverage is very likely to have an effect on the stock’s share price in the near future.

HSTM has been the topic of several recent research reports. Canaccord Genuity reaffirmed a “hold” rating and set a $25.00 target price on shares of HealthStream in a research note on Thursday, July 27th. Zacks Investment Research cut shares of HealthStream from a “buy” rating to a “hold” rating in a research note on Wednesday, July 12th. Needham & Company LLC lowered their target price on shares of HealthStream from $32.00 to $26.00 and set a “buy” rating on the stock in a research note on Wednesday, July 26th. Robert W. Baird reaffirmed an “outperform” rating and set a $35.00 target price on shares of HealthStream in a research note on Tuesday, June 27th. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $24.00 price target (down previously from $28.00) on shares of HealthStream in a research report on Wednesday, July 26th. One analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $26.43.

Shares of HealthStream (NASDAQ:HSTM) traded up 1.42% during mid-day trading on Friday, reaching $22.91. 257,991 shares of the company’s stock were exchanged. HealthStream has a 52 week low of $20.60 and a 52 week high of $31.53. The stock has a 50 day moving average price of $24.95 and a 200 day moving average price of $25.32. The stock has a market cap of $730.51 million, a price-to-earnings ratio of 164.82 and a beta of 0.98.

HealthStream (NASDAQ:HSTM) last announced its quarterly earnings results on Monday, July 24th. The technology company reported $0.08 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.04 by $0.04. HealthStream had a return on equity of 2.27% and a net margin of 1.85%. The company had revenue of $61.48 million during the quarter, compared to analyst estimates of $61.36 million. During the same quarter in the previous year, the firm posted $0.04 EPS. The firm’s quarterly revenue was up 12.2% on a year-over-year basis. Equities research analysts predict that HealthStream will post $0.22 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “HealthStream (HSTM) Earns Daily Media Impact Score of 0.02” was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this piece can be viewed at

About HealthStream

HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.

Insider Buying and Selling by Quarter for HealthStream (NASDAQ:HSTM)

What are top analysts saying about HealthStream Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HealthStream Inc. and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit